AMY KENNEDY: Open Payments
NPI 1922467216 · AMHERST, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 21 payments from 7 companies in 2025. Trend: 2023 $535 · 2024 $621 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $272 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| PFIZER INC. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
Products named: UBRELVY, QULIPTA, VRAYLAR, Auvelity, M-M-R II, SKYRIZI, NURTEC ODT, ROTATEQ.
Industry payments across NH — which companies pay providers there.
